FDA Releases Draft Guidance on Formal Meetings with OTC Monograph Drug Sponsors

Summary

The Food and Drug Administration (FDA) is releasing a draft guidance document outlining recommendations for formal meetings between the agency and companies seeking approval for over-the-counter monograph drugs. The guidance aims to clarify the process for these meetings, which are crucial for the approval of these medications.